Suppr超能文献

四种临床风险评分在院外心脏骤停后昏迷患者中的比较。

Comparison of four clinical risk scores in comatose patients after out-of-hospital cardiac arrest.

机构信息

Department of Clinical Sciences, Anaesthesia and Intensive Care, Lund University, Skåne University Hospital, Malmö, Sweden.

Anaesthesia and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Resuscitation. 2023 Oct;191:109949. doi: 10.1016/j.resuscitation.2023.109949. Epub 2023 Aug 25.

Abstract

BACKGROUND AND AIMS

Several different scoring systems for early risk stratification after out-of-hospital cardiac arrest have been developed, but few have been validated in large datasets. The aim of the present study was to compare the well-validated Out-of-hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP)-scores to the less complex MIRACLE2- and Target Temperature Management (TTM)-scores.

METHODS

This was a post-hoc analysis of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Missing data were handled by multiple imputation. The primary outcome was discriminatory performance assessed as the area under the receiver operating characteristics-curve (AUROC), with the outcome of interest being poor functional outcome or death (modified Rankin Scale 4-6) at 6 months after OHCA.

RESULTS

Data on functional outcome at 6 months were available for 1829 cases, which constituted the study population. The pooled AUROC for the MIRACLE2-score was 0.810 (95% CI 0.790-0.828), 0.835 (95% CI 0.816-0.852) for the TTM-score, 0.820 (95% CI 0.800-0.839) for the CAHP-score and 0.770 (95% CI 0.748-0.791) for the OHCA-score. At the cut-offs needed to achieve specificities >95%, sensitivities were <40% for all four scoring systems.

CONCLUSIONS

The TTM-, MIRACLE2- and CAHP-scores are all capable of providing objective risk estimates accurate enough to be used as part of a holistic patient assessment after OHCA of a suspected cardiac origin. Due to its simplicity, the MIRACLE2-score could be a practical solution for both clinical application and risk stratification within trials.

摘要

背景和目的

已经开发出了几种不同的评分系统,用于对院外心脏骤停后进行早期风险分层,但很少有评分系统在大型数据集上得到验证。本研究的目的是比较经过充分验证的院外心脏骤停(OHCA)和心脏骤停医院预后(CAHP)评分与不太复杂的 MIRACLE2 和目标温度管理(TTM)评分。

方法

这是对目标低温与院外心脏骤停后目标常温治疗(TTM2)试验的事后分析。通过多次插补处理缺失数据。主要结局是通过接受者操作特征曲线下面积(AUROC)评估的判别性能,感兴趣的结局是 OHCA 后 6 个月时功能预后不良或死亡(改良 Rankin 量表 4-6 级)。

结果

共有 1829 例患者的 6 个月时功能结局数据可用,构成了研究人群。MIRACLE2 评分的汇总 AUROC 为 0.810(95%CI 0.790-0.828),TTM 评分的 AUROC 为 0.835(95%CI 0.816-0.852),CAHP 评分的 AUROC 为 0.820(95%CI 0.800-0.839),OHCA 评分的 AUROC 为 0.770(95%CI 0.748-0.791)。在达到特定特异性>95%所需的截止值时,所有四个评分系统的敏感性均<40%。

结论

TTM、MIRACLE2 和 CAHP 评分均能够提供足够准确的客观风险估计,可用于疑似心源性 OHCA 后整体患者评估的一部分。由于其简单性,MIRACLE2 评分可以作为临床试验中临床应用和风险分层的实用解决方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验